The motor symptoms of Parkinson’s disease (PD) correlate with selective, progressive degeneration of midbrain dopamine neurons. Transplantation of autologously derived dopamine neurons, that is, created from the patient’s own cells, has shown promise in a recent clinical study, but survival of the cells has been poor.
